Profile: Nutraplus India Ltd (NUPI.BO)
NUPI.BO on Bombay Stock Exchange
Change (% chg)
Nutraplus India Limited (NPIL) is a veteran producer of bulk drugs/active pharmaceutical ingredients (APIs), specialty chemicals and intermediates for treatment across therapeutic areas. The Company's segments include Active Pharma Ingredients & Intermediates and Pharma Equipments. The Company's core focus is on the APIs/bulk drugs and also on the pain/analgesic drugs. The Company's products include Nimesulide, Bromhexine HCL, Aceclofenac, Lumefantrine, Diclofenac Sodium, Albendazole, Artemether, Lumefantrine, Arteether Ornidazole, Mefenamic acid and Doxofylline. The Company is engaged in the contract manufacturing of intermediates. The Company produces other complex products, such as Meta Chloro Anisloe and Meta Bromo Anisole. The Company operates through its manufacturing facilities located at Tarapur, Boisar, Maharashtra.
Nutraplus India Ltd
H.F. SOCIETY ROAD END